Inrals

International Network of Recruitment Agencies in Life Sciences
Close
  • Our story
  • Why INRALS?
    • Characteristics
    • Facts & Figures
    • Cases
    • Testimonials
  • Network members
  • News
  • Blog
  • Knowledge Centre
    • Shared expertise
    • Downloads
  • Contact
  • Selected vacancies
Menu
INRALS-Member-CK-Group-JobhuntingtrendsinUK-June-2021

Job hunting trends in UK – June 2021

July 5, 2021 - INRALS Member: CK Group

Our UK member CK Group recently surveyed their candidates who have found a new role, to find out the latest trends in job hunting in the UK. Here are the results and their top tips, for both candidates and recruiters.

Download CK Group report – Job hunting trends in UK – June 2021

Tweet
Share
Email
WhatsApp
  • INRALS Intel – Focus on Brazil (including download)
    INRALS Intel – Focus on Brazil (including download)
    September 1, 2021
  • Job hunting trends in Switzerland – June 2021
    Job hunting trends in Switzerland – June 2021
    July 5, 2021
  • INRALS Intel – Focus on Italy (including download)
    INRALS Intel – Focus on Italy (including download)
    June 29, 2021
  • INRALS Intel – Focus on Denmark (including download)
    INRALS Intel – Focus on Denmark (including download)
    May 31, 2021
  • INRALS Intel – Focus on Australia (including download)
    INRALS Intel – Focus on Australia (including download)
    April 21, 2021
  • INRALS Life Sciences Market Intelligence (download)
    INRALS Life Sciences Market Intelligence (download)
    January 15, 2021
  • INRALS Intel – Focus on Spain (including download)
    INRALS Intel – Focus on Spain (including download)
    November 27, 2020
  • INRALS Intel – Focus on Germany (including download)
    INRALS Intel – Focus on Germany (including download)
    November 3, 2020
  • INRALS Intel – Focus on Ireland (including download)
    INRALS Intel – Focus on Ireland (including download)
    September 15, 2020
  • INRALS Intel – Focus on United Kingdom (including download)
    INRALS Intel – Focus on United Kingdom (including download)
    July 17, 2020

inrals  International Network of Recruitment Agencies in Life Sciences

News

  • INRALS General Assembly 2022: celebrating 10 successful years
    May 6, 2022
  • The applicant perspective – Expert Talk with Dilsâd Babayigit
    August 31, 2021
  • INRALS welcomes Precision BioSearch
    July 9, 2021

Twitter

The Flysjo family arrived at #NIH from Sweden just before the border closed in 2020. All 3 children have an ultra-rare, fatal disease called GM1 gangliosidosis. A @genome_gov gene therapy trial has ignited a spark of hope. Read more from @NIHRecord: bit.ly/3SOKZRp

About 12 minutes ago from NIH's Twitter

How to incorporate virtual team-based care into your practice. spr.ly/6012zAJjK

About 14 minutes ago from AMA's Twitter

An annual flu shot is always important, especially in high-risk populations. Hear from our roundtable of health experts on how we can help address health inequities this flu season at: bit.ly/3vZNaI6 pic.twitter.com/ffw0TjJN64

About 19 minutes ago from Sanofi US's Twitter

Cornea made from pig collagen restores sight in blind, visually-impaired people zpr.io/fvqWj3hpidqP #ScienceTwitter

About 23 minutes ago from Medical News Today's Twitter

The reconciliation bill will not only lead to fewer cures and treatments; it also does nothing to hold insurers and middlemen accountable for their abusive practices. Read more from from @npcnow president & CEO @drjmob: twitter.com/drjmob/status/…

About 25 minutes ago from PhRMA's Twitter

“I’ve never wanted to do anything else,” said first-year MD student Josie Wilson during her first week at Harvard Medical School hvrd.me/ZwT530spoP2

About 43 minutes ago from Harvard Medical School's Twitter

Asthma: Scientists investigate new long-term treatment for relief beyond inhalers zpr.io/FSsesbcty2Ne #ScienceTwitter

About 47 minutes ago from Medical News Today's Twitter

#NumbersToKnow: 100 Some estimate as many as 100 fewer treatments and cures will be developed over the next two decades if the latest drug pricing bill becomes law. Bottom line? Patients lose when the government sets the price of medicines. onphr.ma/3vqduLb

About 48 minutes ago from PhRMA's Twitter

Marinus Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) zpr.io/NuKqcdkjNPCV #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews pic.twitter.com/OAx2q3D0ZX

About 53 minutes ago from Pharma & Life Science News's Twitter

Generational Equity Advises Natural Products in its Sale to Grain Processing Corporation zpr.io/krTGYuijKPfe #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews pic.twitter.com/PosCdeULUx

About 53 minutes ago from Pharma & Life Science News's Twitter

Aptinyx's fibromyalgia drug misses Phase II study endpoint $APTX firstwordpharma.com/story/563…

About 54 minutes ago from FirstWord Pharma's Twitter

Up and Down the Ladder: Job Changes.. the latest comings and goings.. recognize anyone? statnews.com/pharmalot/2022… #pharma #biotech #jobs $JNJ $CAH $LLY $PFE $CMRX $RCUS $ENTA $KMPH

About 2 hours ago from pharmalot's Twitter

A sun rash is the most common type of skin disease that occurs due to sunlight. #ScienceTwitter pic.twitter.com/jzwGQVbjHP

About 2 hours ago from Medical News Today's Twitter

Many young people have anxiety, which interferes with their ability to go about their daily lives. 👇🧵 #ScienceTwitter

About 2 hours ago from Medical News Today's Twitter

The latest drug pricing plan is not a “modest proposal.” It disrupts our entire R&D system and threatens patient access to medicines and future innovations. Learn more at PhRMA.org/protectpatients pic.twitter.com/H0DehkDwVw

About 2 hours ago from PhRMA's Twitter

Distrust of medical professionals persists in many patient groups that have been economically or socially marginalized. Learn 3 ways #medstudents can combat mistrust. spr.ly/6013zAJtl

About 2 hours ago from AMA's Twitter

‘Window dressing’: Eli Lilly’s after-the-fact statement on Indiana’s abortion law sends a disingenuous message -- My latest column: feedback, suggestions, criticism are welcome.. statnews.com/2022/08/11/eli… #pharma #abortion #Indiana $LLY

About 2 hours ago from pharmalot's Twitter

A majority of Americans have serious concerns about the reconciliation bill and what the potential consequences would be for their wallets, health and wellbeing – especially after reading the fine print. Take a deeper look: onphr.ma/3PeigCo

About 3 hours ago from PhRMA's Twitter

Pharmalittle: Two children died after getting Novartis gene therapy; monkeypox vaccine maker warns about splitting doses & More news.. statnews.com/pharmalot/2022… #pharma #COVID19 #vaccines #monkeypox #taxes #Zantac $NVS $JNJ $AMGN $GSK $BVNRY $SIGA

About 3 hours ago from pharmalot's Twitter

A Harvard health policy expert explains Amazon’s nearly $4 billion investment in One Medical and what it can, and cannot, do to change the way consumers get their health care news.harvard.edu/gazette/stor…

About 3 hours ago from Harvard Medical School's Twitter

Enzo Biochem to Launch Monkeypox Testing Services this Week zpr.io/DfD2uJVZYSiH #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews pic.twitter.com/THJ3XqpQaf

About 3 hours ago from Pharma & Life Science News's Twitter

The recent meningococcal #meningitis outbreak in FL reminds us that the value of immunization goes beyond helping to avoid disease. Read the latest piece by Dr. Corey Robertson, Senior Director of Scientific and Medical Affairs @NMAtweets linkedin.com/posts/corey-ro…

About 3 hours ago from Sanofi US's Twitter

@SnehaBhowmik10 @SMCoates - why no credit given to STAT for breaking the Novartis story on gene therapy deaths?

About 3 hours ago from pharmalot's Twitter

How is #monkeypox different from #COVID19? @CNN explains. spr.ly/6013zAqWR

About 4 hours ago from AMA's Twitter

SCOOP: Novartis reports two children died from acute liver failure after treatment with Zolgensma gene therapy.. statnews.com/pharmalot/2022… #pharma #genetherapy $NVS

About 4 hours ago from pharmalot's Twitter

Shares in GSK, Sanofi recover after losses on Zantac-related litigation $GSK $SNY $PFE $HLN firstwordpharma.com/story/563…

About 5 hours ago from FirstWord Pharma's Twitter

More German Firms Seek IoT Services for Competitive Edge zpr.io/YVsmKDwyQbs3 #PharmaNews #ClinicalResearchNews #BiotechNews #LifeSciencesNews #MedicalNews #HealthcareNews #PharmiwebNews pic.twitter.com/2JcNQF6Wch

About 5 hours ago from Pharma & Life Science News's Twitter

Training Course: Clinical Quality Management Systems 17-18 Nov 2022 - Online webinar zpr.io/uis2iCt7hTX5 A two-day course that will ensure you comply with new regulatory requirements. pic.twitter.com/RwnxdOwNXi

About 5 hours ago from Pharma & Life Science News's Twitter

Training Course: Clinical Evaluation of Medical Devices: The Clinical Evaluation Report 28-29 Nov 2022 - Online webinar zpr.io/r8atfLjXbCvd Cover all the aspects of clinical evaluation in line with the European medical device regulations and applicable guidance documents pic.twitter.com/0PZNgqpHWs

About 5 hours ago from Pharma & Life Science News's Twitter

Training Course: Medical Device Studies: Regulatory Requirements and Adverse Event Reporting 19-20 Sep 2022 - Online webinar zpr.io/SKTBC6Z7Shyj An essential overview of medical device clinical evaluations, clinical investigations, post-market clinical follow-up requirements pic.twitter.com/WOojVYgAM8

About 5 hours ago from Pharma & Life Science News's Twitter

Contact

INRALS Office Management
(Derks & Derks)
Databankweg 12a
3821 AL Amersfoort
The Netherlands

T  +31 33 472 80 87
E  info@inrals.com
I   www.derksenderks.nl

INRALS B.V.
KvK/CoC 60618604

Follow us

LinkedIn

Twitter

Youtube

Share us

Tweet
Share
Email
WhatsApp
© Copyright - Inrals | Privacy statement | Cookie statement | Webdesign
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Back to Top